Thrombectomy – Diagnostics – Overview of Information and Clinical Research

Understanding how doctors identify blood clots and determine the right treatment approach can help patients recognize when they need urgent medical attention and what to expect during the diagnostic process.

Introduction: Who Needs Diagnostic Testing and When to Seek Help

When blood vessels become blocked by clots, the resulting interruption of blood flow can threaten vital organs and tissues throughout the body. Recognizing when to seek medical attention is critical, as the timing of diagnosis and treatment often determines whether permanent damage can be prevented. People experiencing certain warning signs should seek immediate medical evaluation to determine if a blood clot is present and whether procedures to remove it might be necessary.

Anyone experiencing sudden symptoms such as severe pain, swelling, numbness, or a cold feeling in an arm or leg should seek prompt medical attention. These symptoms may indicate that a blood clot is blocking blood flow to an extremity, which can lead to tissue death if not addressed quickly. In the brain, symptoms like sudden weakness or paralysis on one side of the body, difficulty speaking or understanding speech, or vision problems signal a potential stroke caused by a clot blocking an artery. These neurological symptoms require emergency evaluation because quick treatment can significantly reduce brain damage and improve recovery outcomes.^[1]

The urgency of diagnostic testing varies depending on the location and severity of symptoms. For stroke patients, doctors aim to perform diagnostic procedures and begin treatment within hours of symptom onset. Research has shown that thrombectomy procedures performed within the first few hours after stroke symptoms begin are most effective, though they can benefit certain patients up to 24 hours after symptoms start. This extended time window means that even if several hours have passed since symptoms began, seeking medical attention remains crucial.^[2]

Not everyone with a blood clot requires surgical removal. Some clots can be managed with medications alone, such as anticoagulants (drugs that thin the blood to prevent new clots from forming) or thrombolytics (medications that dissolve existing clots). The diagnostic process helps doctors determine whether a clot can be treated with medication or whether a thrombectomy procedure is needed. Generally, doctors consider thrombectomy when medications cannot effectively treat the clot, when the clot is too large to dissolve with medication alone, or when the clot blocks blood flow in a way that puts the patient at immediate risk of death or permanent organ damage.^[1]

⚠️ Important

Blood clots in the brain, heart, or lungs represent medical emergencies that require immediate attention. Sometimes thrombectomy must be performed within a matter of hours to prevent life-threatening or limb-threatening complications. If you experience sudden severe symptoms like chest pain, difficulty breathing, sudden weakness, or severe pain in a limb, seek emergency medical care immediately rather than waiting for a scheduled appointment.

Diagnostic Methods for Identifying Blood Clots

When patients arrive at a medical facility with symptoms suggesting a blood clot, doctors use several diagnostic approaches to confirm the presence of a clot, determine its exact location and size, and assess whether it can be safely removed. The diagnostic process typically begins with a physical examination and continues with various imaging tests that allow doctors to visualize the blood vessels and identify blockages.

Physical Examination and Clinical Assessment

The diagnostic journey often starts with doctors evaluating the patient’s symptoms and performing a physical examination. For patients with suspected blood clots in the limbs, doctors look for signs such as swelling, discoloration, pain when pressing on the affected area, and differences in temperature between the affected and unaffected limbs. They may check pulses in various locations to assess blood flow. For stroke patients, doctors perform neurological examinations to assess speech, movement, sensation, and other brain functions that might be affected by reduced blood flow.^[13]

A critical part of the initial assessment involves determining when symptoms began. This information helps doctors decide which treatment options are most appropriate and whether time-sensitive procedures like thrombectomy remain viable options. Doctors also review the patient’s medical history, including any previous blood clots, bleeding disorders, or other conditions that might affect treatment decisions.^[1]

Imaging Tests to Visualize Blood Clots

Once doctors suspect a blood clot based on symptoms and physical examination, they use various imaging technologies to confirm the diagnosis and visualize the clot’s exact location. Different imaging methods are used depending on which part of the body is affected and how quickly results are needed.

For patients with suspected stroke, computed tomography or CT scanning is often the first imaging test performed. CT scans use X-rays to create detailed cross-sectional images of the brain, allowing doctors to quickly distinguish between strokes caused by blood clots and those caused by bleeding in the brain. This distinction is crucial because the treatments for these two types of stroke are completely different. CT scans can be performed rapidly, which is essential in emergency situations where every minute counts.^[6]

Another imaging technique used during the diagnostic process involves injecting a special dye into the blood vessels. This dye shows up on X-ray images, allowing doctors to see the blood vessels in detail and identify where blockages occur. During thrombectomy procedures, doctors use continuous X-ray imaging called fluoroscopy to watch in real-time as they guide instruments through the blood vessels to reach the clot. This imaging guidance is essential for safely navigating the complex network of blood vessels and ensuring that instruments reach the correct location.^[6]

Ultrasound imaging uses sound waves to create pictures of structures inside the body and is particularly useful for detecting blood clots in veins and arteries near the body’s surface. For example, ultrasound can identify clots in the leg veins that cause deep vein thrombosis, or DVT. The ultrasound probe can be moved over the skin to examine different areas, making it a non-invasive and comfortable diagnostic option for many patients.^[1]

Specialized Assessments for Stroke Patients

For patients experiencing stroke symptoms, doctors use specialized scoring systems to help determine whether thrombectomy is appropriate. These assessments evaluate the severity of neurological symptoms and help predict how much benefit a patient might receive from the procedure. One commonly used tool is the NIH Stroke Scale, which assigns numerical scores to various aspects of neurological function such as consciousness, vision, movement, sensation, and language abilities.^[2]

Doctors also use the Alberta Stroke Program Early CT Score, which involves examining CT scan images to determine how much brain tissue has already been damaged by the stroke. This information helps doctors assess whether enough healthy brain tissue remains that could be saved by removing the clot. These scoring systems provide standardized ways to evaluate stroke severity and guide treatment decisions based on evidence from clinical research.^[2]

Tests to Rule Out Contraindications

The diagnostic process also involves identifying conditions that might make thrombectomy unsafe or less likely to succeed. Doctors need to determine whether patients have conditions that would classify them as poor candidates for the procedure. These exclusion criteria help protect patients from unnecessary risks.

Certain conditions may prevent doctors from recommending thrombectomy. Patients with bleeding in the brain, called intracranial hemorrhage, generally cannot safely undergo thrombectomy procedures designed to remove clots, as the procedure could worsen bleeding. Similarly, patients with very high blood pressure that cannot be controlled with medication face increased risks from the procedure. Blood tests help identify patients with pre-existing blood disorders that affect clotting, as these conditions can complicate both the procedure and recovery.^[1]

The location and characteristics of the clot itself also factor into diagnostic decisions. Doctors assess whether the clot is in a location that can be safely reached with current instruments and techniques. Very small blood vessels may be too narrow to safely access, while clots in certain hard-to-reach locations may pose excessive risks. Additionally, chronic clots that have been present for more than 30 days typically cannot be effectively removed through thrombectomy, as they become more firmly attached to blood vessel walls over time.^[1]

⚠️ Important

The diagnostic process must be completed quickly in emergency situations, but thoroughness remains essential. Doctors must balance the urgency of starting treatment with the need to gather sufficient information to ensure that thrombectomy is the safest and most appropriate option for each individual patient. Even when time is limited, proper diagnostic evaluation protects patients from unnecessary risks.

Diagnostic Criteria for Clinical Trial Participation

Clinical trials studying thrombectomy procedures use specific diagnostic criteria to determine which patients can participate. These standardized criteria ensure that research findings are reliable and that trial participants are likely to benefit from the experimental approaches being studied. Understanding these criteria provides insight into how doctors evaluate patients for thrombectomy in both research and routine clinical settings.

Standard Criteria for Stroke Thrombectomy Trials

Major clinical trials that established thrombectomy as an effective treatment for stroke used detailed inclusion criteria based on diagnostic tests and assessments. The American Heart Association and American Stroke Association have published guidelines based on these trials that recommend specific criteria for selecting patients who should receive mechanical thrombectomy for stroke.^[2]

One key criterion involves the patient’s pre-stroke functional status, measured using the modified Rankin Scale. This scale ranges from 0 (no symptoms) to 6 (death) and describes the degree of disability. Clinical trial guidelines typically recommend thrombectomy for patients who had a modified Rankin Scale score less than 2 before their stroke, meaning they were living independently with no or minimal disability. This criterion helps identify patients who have the potential to return to good functional status if the clot is successfully removed.^[2]

The NIH Stroke Scale score mentioned earlier also serves as an enrollment criterion, with many trials requiring a score of 6 or higher, indicating moderate to severe stroke symptoms. This threshold helps identify strokes serious enough that the potential benefits of thrombectomy outweigh the procedure’s risks. Similarly, the Alberta Stroke Program Early CT Score of 6 or higher indicates that sufficient healthy brain tissue remains that could potentially be saved by restoring blood flow.^[2]

Time Windows and Imaging Requirements

Historically, clinical trials established a 6-hour window from symptom onset to the start of the thrombectomy procedure as the standard timeframe for treatment. This deadline reflected the understanding that brain tissue dies rapidly when deprived of blood flow, and that intervention must occur while there is still viable tissue to save. However, more recent clinical trials, including the landmark DAWN and DEFUSE-3 studies, have demonstrated that carefully selected patients can benefit from thrombectomy even when treated between 6 and 24 hours after symptom onset.^[2]

These newer trials used advanced imaging techniques to identify patients with favorable characteristics who could benefit from treatment beyond the original 6-hour window. The extended time window represents a major advancement that has made thrombectomy available to many more patients, particularly those who wake up with stroke symptoms or who experience symptom progression over time.^[4]

Clinical trials also specify which blood vessel locations qualify for treatment. Most stroke thrombectomy trials have focused on blockages in the internal carotid artery or the proximal middle cerebral artery (M1 segment), which are large vessels whose blockage typically causes severe strokes. These specific anatomical requirements ensure that the clot is accessible to the instruments used during thrombectomy and large enough that its removal is likely to make a meaningful difference in outcome.^[2]

Age and Additional Eligibility Factors

Most clinical trials studying thrombectomy in adults have required participants to be at least 18 years old. This age criterion reflects the different physiology and disease patterns in children compared to adults, as well as the need for specialized pediatric expertise when treating younger patients. While age is used as an enrollment criterion in trials, individual treatment decisions in clinical practice consider many factors beyond age alone, including overall health status and life expectancy.^[2]

Beyond the core imaging and clinical criteria, trials may include additional requirements related to patients’ overall medical condition, the availability of specific expertise and equipment, and the ability to obtain informed consent. These factors help ensure patient safety during research while also generating reliable data about thrombectomy’s effectiveness under controlled conditions.

The diagnostic criteria used in clinical trials have directly influenced how doctors evaluate patients for thrombectomy in everyday practice. As new trial results emerge and expand our understanding of which patients benefit most from the procedure, diagnostic criteria continue to evolve. This ongoing refinement helps ensure that thrombectomy is offered to patients who are most likely to experience improved outcomes while protecting those who would not benefit or who might face excessive risks.

Prognosis and Survival Rate

Prognosis

The outlook for patients who undergo thrombectomy depends heavily on how quickly the procedure is performed after symptoms begin and the extent of damage that has already occurred before blood flow is restored. For stroke patients, thrombectomy can significantly improve recovery and lower the risk of death when performed promptly. By removing the blood clot and restoring blood flow to the brain, the procedure helps reduce brain damage, meaning fewer brain cells die and there is a lower chance of serious long-term disability.^[3]

Recovery after thrombectomy varies considerably from person to person. Some patients notice improvement in their symptoms quickly, while others require more time and extensive rehabilitation support. The amount of brain or tissue damage that occurred before blood flow was restored plays a major role in determining recovery. In general, the less damage to brain tissue or other organs, the less disability results and the better the chances of meaningful recovery. Rehabilitation services such as physical therapy, occupational therapy, and speech therapy often form essential components of recovery, helping patients regain lost skills and independence.^[3]

It is important to understand that no treatment can guarantee a complete recovery from a stroke or other serious blood clot. However, thrombectomy improves the chances of having less disability or no disability after a stroke compared to treatment with medications alone. The procedure has been shown to improve clinical outcomes versus standard care in carefully selected patients, particularly those with large vessel blockages.^[6]

Several factors influence individual prognosis beyond the thrombectomy procedure itself. The patient’s age, overall health before the event, the specific location of the blood clot, and the presence of other medical conditions all contribute to outcomes. Patients who were living independently and had good functional status before their stroke generally have better recovery potential than those who already had significant disabilities or health problems.^[2]

Survival rate

Thrombectomy can greatly reduce the risk of death when performed promptly for life-threatening blood clots. The procedure is particularly effective at preventing death in cases where clots block major arteries supplying the brain, heart, or other vital organs. By quickly restoring blood flow, thrombectomy prevents the cascade of organ damage that would otherwise lead to death or severe permanent disability.^[1]

While specific survival statistics vary depending on the location and size of the blood clot, the underlying health of the patient, and how quickly treatment is initiated, research has consistently demonstrated that thrombectomy improves survival rates compared to medication treatment alone in appropriately selected patients. Clinical trials studying thrombectomy for stroke have shown reduced mortality rates among patients who received the procedure within appropriate time windows compared to those who received only standard medical therapy.^[2]

The timing of treatment remains one of the most critical factors affecting survival. Patients who receive thrombectomy within the first few hours of symptom onset have the best chances of survival and recovery. Even within the extended time window up to 24 hours after symptom onset, selected patients can experience significant benefits, though outcomes generally improve the sooner treatment begins. This relationship between timing and outcomes emphasizes why seeking immediate medical attention at the first sign of symptoms is so crucial.^[3]

#1 Clinical Trials Search in Europe